Scientists reconstruct bat variant of SARS coronavirus
New research from University of California, Davis, shows why a species of tiny worm can learn to ignore an odor - information that could have implications for how human memories are formed. Scientists have known for decades that sensory neurons - nerves in places like our fingers, ears and eyes - begin the complex task of
Full Post: Odors can alter gene expression in an olfactory neuron
Researchers at the University of North Carolina at Chapel Hill and Vanderbilt University Medical Center have synthetically reconstructed the bat variant of the SARS coronavirus (CoV) that caused the SARS epidemic of 2003.
The scientists say designing and synthesizing the virus is a major step forward in their ability to find effective vaccines and treatments for any strain of SARS virus that might affect humans in the future.
A report of the work is due to appear in the latest Proceedings of the National Academy of Sciences Early Edition, which publishes papers online and later in print.
“Only three other teams of researchers have synthetically reconstructed a virus. In this case we reconstructed the likely progenitor of the SARS-CoV epidemic,” said Ralph Baric, Ph.D., epidemiology professor at the UNC Gillings School of Global Public Health and one of the leaders on the project. “The bat SARS virus is about four times larger than any other virus that has been synthesized to date. It will allow us to test the pathways in which the virus emerges and understand the ways that animal coronaviruses move from one species to another.”
Baric and his team of epidemiology researchers worked with counterparts at Vanderbilt University Medical Center led by Mark Denison, M.D., professor of microbiology and pediatrics. The two teams collaborated closely to review the existing sequences of all bat SARS viruses; predict the actual sequence of the bat SARS-CoV that would be able to grow; design the synthesis of the genome; and recover and characterize the viruses that were synthetically reconstructed and rescued in the laboratory. They also studied the pathogenesis and the ability of therapeutics targeting epidemic strains to cure bat SARS-CoV infection.
SARS (severe acute respiratory syndrome) is believed to have first emerged humans in Asia in late 2002. Over the next several months, the illness spread to more than two dozen countries in North America, South America, Europe and Asia before the global outbreak was contained. Of the more than 8,000 people worldwide who were diagnosed with SARS in 2003, 774 died.
Baric said SARS is believed to have originated in bats, and “jumped” to humans either directly or through raccoon dogs and palm civets, both considered delicacies for humans in China.
“Although the strains associated with the 2002-2003 epidemic no longer circulate in humans, the animal precursor strains are common and will likely re-emerge in the future,” he said. “The key problem is that many of the vaccines and therapeutics targeting the 2002-2003 epidemic strains may not work against future emergent strains.”
Baric said synthesizing the SARS co-variant that infects bats and then modifying it so that it can grow well in laboratory animals will allow researchers to search for vaccines and treatments that would be effective against any strain of SARS that might infect humans in the future. Viruses that start in animals and mutate to infect humans tend to be slightly different each year. An example is the influenza virus, which is different each year and requires a different vaccine each year to provide immunity.
“By reconstructing the synthetic bat SARS virus, we have a model that will allow us to design better vaccines and drugs that will treat any strain of this virus that infects humans,” Baric said.
The value of the research goes beyond SARS, he added.
“Potentially, we can apply this technology to many other emerging viruses,” he said. “Then, perhaps we wouldn’t have to develop a new therapy each year, but can find treatments that will be effective against all of the root viruses.”
SARS - severe acute respiratory syndrome - alarmed the world five years ago as the first global pandemic of the 21st century. The coronavirus (SARS-CoV) that sickened more than 8,000 people - and killed nearly 800 of them - may have originated in bats, but the actual animal source is not known. In an effort to understand
Full Post: Researchers generate synthetic SARS-like bat coronavirus
A virus that causes cold-like symptoms in humans originated in birds and may have crossed the species barrier around 200 years ago, according to an article published in the December issue of the Journal of General Virology. Scientists hope their findings will help us understand how potentially deadly viruses emerge in humans. “Human metapneumovirus may
Full Post: Common cold virus originated in birds
Although infection control has been substantially ramped up in Canadian hospitals since the SARS crisis of 2003, the number of resistant bacterial infections post-SARS have multiplied even faster, a new Queen’s University study shows. Led by Queen’s epidemiologist Dr. Dick Zoutman, the national survey is a six-year follow-up to a study that was undertaken in
Full Post: Superbugs on the rise in Canadian hospitals
The secrets of why the 1918 flu pandemic was such a deadly one have been revealed by team of Japanese and American scientists. The team discovered that the reason it was so deadly was because a group of three genes allows the virus to invade the lungs and cause pneumonia. They discovered the three
Full Post: Secrets revealed into devastating 1918 flu pandemic
As the Dengue fever outbreak in Cairns continues unabated a health official has said the outbreak is the worst in Queensland since World War II times. The number of confirmed cases has now reached epidemic levels with more than 160 reported in recent weeks. Dr. Linda Selvey from the Tropical Population Health says 167 cases
Full Post: Queensland Dengue epidemic continues unabated